MedTrace Logo

In Vitro Model of the Cystic Fibrosis Bronchial Epithelium Via iPS Technology

NCT03754088 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6

Last updated 2022-09-26

No results posted yet for this study

Summary

In order to further enable physiopathology studies, the aim of this project is to validate an in vitro model of cystic fibrosis created using induced pluripotent stemcell (iPS) differentiated bronchial epithelium from cystic fibrosis (CF) patients homozygous for the p.Phe508del mutation of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Conditions

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Arnaud Bourdin, MD, PhD · Montpellier University Hospitals

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-05
Primary Completion
2019-04-25
Completion
2019-04-25

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03754088 on ClinicalTrials.gov